Literature DB >> 33466517

Complementary Methods in Cancer Treatment-Cure or Curse?

Kaja Michalczyk1, Jakub Pawlik1, Izabela Czekawy1, Mateusz Kozłowski1, Aneta Cymbaluk-Płoska1.   

Abstract

(1) Background: The prevalence of complementary and alternative methods (CAM) use among oncological patients has been rising constantly over the last few decades and a variety of both pharmacological and non-pharmacological methods have been developed. Many advertisements promise to relieve side effects of chemotherapy or even to cure the disease, thus encouraging patients to use CAM; (2)
Methods: The objective of the study was to determine which patients' characteristics are associated with the use of complementary medicine during cancer treatment, their pattern of use, and if it has any association with its safety profile. This survey-based prospective multicenter study of 316 patients examined the use of complementary medicine among patients undergoing chemotherapy treatment in cancer centers in Poland between 2017 and 2019; (3)
Results: The Chi2 analysis showed that patients' opinion regarding the safety of unconventional methods is related to the use of CAM (p = 0.00147). Moreover, patients' thinking that alternative medicine can replace traditional therapy was correlated with his/her education (p = 0.01198). Moreover, we performed univariate and multivariate analysis to determine factors associated with CAM use including sociodemographic and clinical characteristics. Finally, we conducted survival analysis of patients undergoing chemotherapy treatment with 42 months of follow-up time of our prospective study. Using Kaplan-Meier curves and log-rank analysis, we found no statistical difference in overall survival between the groups that used and did not use any form of CAM (p = 0.211); (4) Conclusions: CAM use is common among patients undergoing chemotherapy treatment and should be considered by medical teams as some agents may interact with chemotherapy drugs and affect their efficacy or cause adverse effects.

Entities:  

Keywords:  alternative treatment; cancer; chemotherapy; complementary medicine

Mesh:

Year:  2021        PMID: 33466517      PMCID: PMC7796472          DOI: 10.3390/ijerph18010356

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  30 in total

1.  Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway.

Authors:  T Risberg; S Kaasa; E Wist; H Melsom
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

2.  Use of complementary medicine by adult patients participating in cancer clinical trials.

Authors:  A Sparber; L Bauer; G Curt; D Eisenberg; T Levin; S Parks; S M Steinberg; J Wootton
Journal:  Oncol Nurs Forum       Date:  2000-05       Impact factor: 2.172

3.  Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis.

Authors:  Neha Vapiwala; Rosemarie Mick; Margaret K Hampshire; James M Metz; Albert S DeNittis
Journal:  Cancer J       Date:  2006 Nov-Dec       Impact factor: 3.360

4.  An analysis of paper-based sources of information on complementary therapies.

Authors:  J Bott
Journal:  Complement Ther Clin Pract       Date:  2006-03-30       Impact factor: 2.446

5.  Use of Alternative Medicine for Cancer and Its Impact on Survival.

Authors:  Skyler B Johnson; Henry S Park; Cary P Gross; James B Yu
Journal:  J Natl Cancer Inst       Date:  2018-01-01       Impact factor: 13.506

6.  Quality and safety issues of web-based information about herbal medicines in the treatment of cancer.

Authors:  Alexander Molassiotis; Min Xu
Journal:  Complement Ther Med       Date:  2004-12       Impact factor: 2.446

7.  Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.

Authors:  Grace K Dy; Lishan Bekele; Lorelei J Hanson; Alfred Furth; Sumithra Mandrekar; Jeff A Sloan; Alex A Adjei
Journal:  J Clin Oncol       Date:  2004-12-01       Impact factor: 44.544

8.  Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center.

Authors:  T Zeller; K Muenstedt; C Stoll; J Schweder; B Senf; E Ruckhaeberle; S Becker; H Serve; J Huebner
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-26       Impact factor: 4.553

9.  An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies.

Authors:  Marisa A Navo; Julie Phan; Christy Vaughan; J Lynn Palmer; Laura Michaud; Kellie L Jones; Diane C Bodurka; Karen Basen-Engquist; Gabriel N Hortobagyi; John J Kavanagh; Judith A Smith
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

Review 10.  Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials.

Authors:  Gina Nauman; Javaughn Corey Gray; Rose Parkinson; Mark Levine; Channing J Paller
Journal:  Antioxidants (Basel)       Date:  2018-07-12
View more
  2 in total

Review 1.  Online Medical Misinformation in Cancer: Distinguishing Fact From Fiction.

Authors:  Eleonora Teplinsky; Sara Beltrán Ponce; Emily K Drake; Ann Meredith Garcia; Stacy Loeb; G J van Londen; Deanna Teoh; Michael Thompson; Lidia Schapira
Journal:  JCO Oncol Pract       Date:  2022-03-31

2.  Complementary and Alternative Medicine Use in Hospitalized Cancer Patients-Study from Silesia, Poland.

Authors:  Karolina Kasprzycka; Marta Kurzawa; Malgorzata Kucharz; Monika Godawska; Marta Oleksa; Marta Stawowy; Katarzyna Slupinska-Borowka; Wiktoria Sznek; Iwona Gisterek; Agnieszka Boratyn-Nowicka; Monika Rucinska; Karolina Osowiecka; Sergiusz Nawrocki
Journal:  Int J Environ Res Public Health       Date:  2022-01-30       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.